Proceedings of the 5th International Symposium on EQUINE ...
Proceedings of the 5th International Symposium on EQUINE ...
Proceedings of the 5th International Symposium on EQUINE ...
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Equine Embryo TransferTABLE 1: Success rates <str<strong>on</strong>g>of</str<strong>on</strong>g> inducti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> ovulati<strong>on</strong> in Experiments 1 and 3Exp 1 (72 paired oestrous cycles) Exp 3 (60 paired oestrous cycles)Busereline Placebo P Busereline Busereline P40 µg x4 40 µg x4 20 µg x4Ovulati<strong>on</strong> within 48 hafter 1st injecti<strong>on</strong> 61% 22% < 0.00 183% 90% N.S.Ovulati<strong>on</strong> between 24and 48 h after1st injecti<strong>on</strong> 47% 14% < 0.054 7% 57% N.S.TABLE 2: success rates <str<strong>on</strong>g>of</str<strong>on</strong>g> inducti<strong>on</strong> <str<strong>on</strong>g>of</str<strong>on</strong>g> ovulati<strong>on</strong> in Experiment 4 and 5Exp 4 (50 paired oestrous cycles) Exp 5 (60 paired oestrous cycles)Busereline hCG P Busereline hCG P20 µg x 4 2500 ui 13.3 µg x 3 2500 uiOvulati<strong>on</strong> between32 and 48 hafter 1st injecti<strong>on</strong> 56 % 76 % N.S. 57 % 50 % N.S.Mean time <str<strong>on</strong>g>of</str<strong>on</strong>g>ovulati<strong>on</strong> ± sd 39.5 ± 3.1 h38.4 ± 2.5 h N.S .43.1 ± 2.1 h 37.7 ± 2.3 h < 0.01<str<strong>on</strong>g>of</str<strong>on</strong>g> ovulati<strong>on</strong> did not differ significantly between<str<strong>on</strong>g>the</str<strong>on</strong>g> 2 treatments (busereline 3 x 13.3 µg or hCG2,500 ui). However, <str<strong>on</strong>g>the</str<strong>on</strong>g>re were many earlysp<strong>on</strong>taneous ovulati<strong>on</strong>s within 32 h after <str<strong>on</strong>g>the</str<strong>on</strong>g> start<str<strong>on</strong>g>of</str<strong>on</strong>g> treatment quite <strong>on</strong>ly in cycles treated with hCG(11/30 versus 1/30). When ovulati<strong>on</strong> occurredbetween 32 and 48 h after <str<strong>on</strong>g>the</str<strong>on</strong>g> first or <str<strong>on</strong>g>the</str<strong>on</strong>g> <strong>on</strong>lyinjecti<strong>on</strong>, <str<strong>on</strong>g>the</str<strong>on</strong>g>re was a significant difference(P